4//SEC Filing
Shalev Varda 4
Accession 0000950170-24-103113
CIK 0000818686other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 7:40 AM ET
Size
7.1 KB
Accession
0000950170-24-103113
Insider Transaction Report
Form 4
Shalev Varda
Director
Transactions
- Exercise/Conversion
Ordinary Shares
2024-09-02+12,872→ 12,872 total - Exercise/Conversion
Restricted Share Units
2024-09-02−12,872→ 0 total→ Ordinary Shares (12,872 underlying)
Footnotes (3)
- [F1]The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
- [F2]Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share.
- [F3]Restricted share units were granted on September 2, 2023 and vested on September 2, 2024.
Documents
Issuer
TEVA PHARMACEUTICAL INDUSTRIES LTD
CIK 0000818686
Entity typeother
Related Parties
1- filerCIK 0001873934
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 7:40 AM ET
- Size
- 7.1 KB